Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection

NCT01653236 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Genotype 4 Chronic Hepatitis C Infection

Interventions

DRUG: Boceprevir
DRUG: Peginterferon alfa-2b
DRUG: ribavirin

Sponsor

Theodor Bilharz Research Institute